Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review

BACKGROUND: The classical psychedelics, psilocybin, peyote, ayahuasca/N,N-dimethyltryptamine, and lysergic acid diethylamide are considered promising new treatments for psychiatric illnesses, such as depression, anxiety, addiction, and obsessive-compulsive disorders. However, their profound and char...

Descripción completa

Detalles Bibliográficos
Autores principales: Hovmand, Oliver Rumle, Poulsen, Emil Deleuran, Arnfred, Sidse, Storebø, Ole Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350724/
https://www.ncbi.nlm.nih.gov/pubmed/37403379
http://dx.doi.org/10.1177/02698811231180276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350724/
https://www.ncbi.nlm.nih.gov/pubmed/37403379
http://dx.doi.org/10.1177/02698811231180276

Ejemplares similares